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Abstract

Cannabis use is highly prevalent and often considered to be relatively harmless. Nonetheless, a subset of
regular cannabis users may develop dependence, experiencing poorer quality of life and greater mental health
problems relative to non-dependent users. The neuroanatomy characterizing cannabis use versus dependence
is poorly understood. We aimed to delineate the contributing role of cannabis use and dependence on
morphology of the hippocampus, one of the most consistently altered brain regions in cannabis users, in a
large multi-site dataset aggregated across four research sites. We compared hippocampal volume and vertexlevel hippocampal shape differences (1) between 121 non-using controls and 140 cannabis users; (2)
between 106 controls, 50 non-dependent users and 70 dependent users; and (3) between a subset of 41
controls, 41 non-dependent users and 41 dependent users, matched on sample characteristics and cannabis
use pattern (onset age and dosage). Cannabis users did not differ from controls in hippocampal volume or
shape. However, cannabis-dependent users had significantly smaller right and left hippocampi relative to
controls and non-dependent users, irrespective of cannabis dosage. Shape analysis indicated localized
deflations in the superior-medial body of the hippocampus. Our findings support neuroscientific theories
postulating dependence-specific neuroadaptations in cannabis users. Future efforts should uncover the
neurobiological risk and liabilities separating dependent and non-dependent use of cannabis.
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ABSTRACT
Cannabis use is highly prevalent and often considered to be relatively harmless.
Nonetheless, a subset of regular cannabis users may develop dependence,
experiencing poorer quality of life and greater mental health problems relative
to non‐dependent users. The neuroanatomy characterising cannabis use versus
dependence is poorly understood. We aimed to delineate the contributing role of
cannabis use and dependence on morphology of the hippocampus, one of the
most consistently altered brain regions in cannabis users, in a large multisite
dataset aggregated across four research sites. We compared hippocampal
volume, and vertex‐level hippocampal shape differences (i) between 121 non‐
using controls and 140 cannabis users; (ii) between 106 controls, 50 non‐
dependent users, and 70 dependent users; and (iii) between a subset of 41
controls, 41 non‐dependent users, and 41 dependent users, matched on sample
characteristics and cannabis use pattern (onset age and dosage). Cannabis users
did not differ from controls in hippocampal volume or shape. However,
cannabis‐dependent users had significantly smaller right and left hippocampi
relative to controls and non‐dependent users, irrespective of cannabis dosage.
Shape analysis indicated localised deflations in the superior‐medial body of the
hippocampus. Our findings support neuroscientific theories postulating
dependence‐specific neuroadaptations in cannabis users. Future efforts should
uncover the neurobiological risk and liabilities separating dependent and
nondependent use of cannabis.
Keywords: cannabis, dependence, hippocampus, MRI, neuroimaging, substance
use
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INTRODUCTION
Cannabis use has been widespread globally over the past two decades, with the
most recent census estimating a prevalence of up to 183 million users (United
Nations Office on Drugs and Crime 2016). This number may increase with recent
legislative changes and more liberal policies surrounding both recreational and
medicinal cannabis use, fueling debate on public health consequences, such as
the potential increase in cannabis dependence and cannabis‐related problems
(Hasin, Sarvet, Cerdá, Keyes, Stohl, Galea & Wall 2017). Despite a general
community perception of harmlessness, a subset of regular cannabis users – over
13 million – are dependent on cannabis (Degenhardt, Ferrari, Calabria, Hall,
Norman, McGrath, Flaxman, Engell, Freedman, Whiteford & Vos 2013; United
Nations Office on Drugs and Crime 2016). In addition, almost 50% of substance
users seeking treatment are cannabis dependent (United Nations Office on Drugs
and Crime 2016). Cannabis dependence represents a significant burden on the
individual and society but has been poorly defined neurobiologically compared
to heavy, non‐dependent use. This warrants greater attention to distinctions
between

cannabis

use

and

dependence,

and

associated

harms

and

vulnerabilities.
Individuals with cannabis dependence report diminished control over use and
compulsive use despite associated negative consequences to their functioning
and mental health (American Psychiatric Association 2013; van der Pol,
Liebregts, De Graaf, Ten Have, Korf, Van den Brink & Van Laar 2013a). Relative
to non‐dependent users, they also experience greater mental health issues (i.e.
mood, anxiety, and conduct disorder) (van der Pol et al. 2013a) and impaired
cognitive functioning in the domains of learning, working memory, and cognitive
flexibility (Solowij & Battisti 2008; Broyd, van Hell, Beale, Yücel & Solowij 2016).
Such impaired functioning may be underpinned by neuroanatomical alterations
across brain regions relevant to motivation, emotion and cognition (Koob 2009;
Chambers 2013), as demonstrated in regular cannabis users with higher levels of
use and problem use (Koenders, Cousijn, Vingerhoets, Van Den Brink, Wiers,
Meijer, Machielsen, Veltman, Goudriaan & De Haan 2016; Lorenzetti, Solowij &
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Yücel 2016c). In particular, the hippocampus is often suggested to be affected by
cannabis users, with a number of studies reporting hippocampal volume to be
reduced in regular cannabis users relative to non‐users (Yücel, Solowij,
Respondek, Whittle, Fornito, Pantelis & Lubman 2008; Yücel, Lorenzetti, Suo,
Zalesky, Fornito, Takagi, Lubman & Solowij 2016; Demirakca, Sartorius, Ende,
Meyer, Welzel, Skopp, Mann & Hermann 2011; Ashtari, Avants, Cyckowski,
Cervellione, Roofeh, Cook, Gee, Sevy & Kumra 2011; Rocchetti, Crescini,
Borgwardt, Caverzasi, Politi, Atakan & Fusar‐Poli 2013; Koenders et al. 2016).
However, almost as many studies have not observed cannabis‐use‐related
hippocampal alterations (Gilman et al., 2014; Mashhoon et al., 2015; Medina et
al., 2007; Tzilos et al., 2005; Weiland et al., 2015). The wide‐ranging sample
characteristics across studies (e.g. average duration of use range from 3 to 20
years; average age of user sample range from 20 to 40 years old), the small
sample size of individual studies (i.e., range of cannabis‐using sample from 11 to
61), and the lack of consideration of cannabis dependence, preclude
identification of key factors involved in specific hippocampal aberrations.
Emerging evidence demonstrates differences between non‐dependent and
dependent cannabis users in brain structure (i.e. orbitofrontal cortex (OFC) and
hippocampal volume (Chye, Suo, Yücel, den Ouden, Solowij & Lorenzetti 2017b;
Chye, Solowij, Suo, Batalla, Cousijn, Goudriaan, Martin‐Santos, Whittle, Lorenzetti
& Yücel 2017a)) and brain function (i.e. functional connectivity across amygdala,
anterior cingulate, OFC, hippocampus, and nucleus accumbens (Filbey & Dunlop
2014)). Such findings may reflect neural adaptations that discriminate
compulsive use in substance dependence (Koob 2009; Chambers 2013; Koob &
Volkow 2017). However, most previous studies of regular cannabis users have
not clarified the differences specific to dependence vs. non‐dependence in
regular cannabis users. It is important to distinguish between these groups to
improve identification and prevention in user populations most vulnerable to
cannabis‐related harms.
We aimed to delineate the contributing roles of cannabis use and dependence on
the hippocampus, one of the most consistently reported brain regions to be
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altered in cannabis users (Lorenzetti et al. 2016c), by re‐examining hippocampal
morphology across an aggregated sample of 261 cannabis users (dependent and
non‐dependent) and non‐using controls from four research sites globally
(Batalla, Soriano‐mas, López‐solà, Torrens, Crippa, Bhattacharyya, Blanco‐hinojo,
Fagundo, Harrison, Nogué, Torre, Farré, Pujol & Martín‐santos 2013; Solowij,
Walterfang, Lubman, Whittle, Lorenzetti, Styner, Velakoulis, Pantelis & Yücel
2013; Cousijn, Vingerhoets, Koenders, De Haan, Van Den Brink, Wiers &
Goudriaan 2014; Yücel et al. 2016). While the aforementioned study findings
have been mixed in relation to hippocampal morphology in diverse cannabis
using samples, none of these studies specifically examined cannabis dependence
relative to non‐dependent heavy use. We compared hippocampal morphology
(i.e. both volume and shape) between (i) regular cannabis users (CB) and non‐
using controls (CON), and between (ii) dependent users (CB‐dep), non‐
dependent users (CB‐nondep), and controls (CON). To validate potential
dependence‐related

hippocampal

morphological

differences, we

further

examined hippocampal volume and shape between (iii) a subset of CB‐dep, CB‐
nondep, and CON, matched on age, gender distribution, IQ, and alcohol use, with
CB‐dep and CB‐nondep further matched on tobacco use and cannabis use (i.e.
onset and dosage). We hypothesised that hippocampal volume reduction and
shape alteration would be apparent in regular cannabis users (both CB‐dep and
CB‐nondep) relative to CON, and that these effects would be more pronounced in
CB‐dep relative to CB‐nondep.
METHOD
Participants
Participants comprising 121 CON (aged 18 to 55; Mdn = 24 years) and 140 CB
(aged 18 to 56; Mdn = 24 years), were recruited from four independently
conducted studies across Amsterdam (N = 76; Cousijn et al., 2014), Barcelona (N
= 55; Batalla et al., 2013), Wollongong (N = 30; Solowij et al., 2013) and
Melbourne (N = 100; Yücel et al., 2016). Inclusion and exclusion criteria have
been documented in a previous paper (Chye et al. 2017a), and in the
Supplementary Table S1. Briefly, CB had to have used cannabis at least two days
per month for at least two months, although most CB had almost daily cannabis
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use for a considerable period of time (duration of regular use, Mdn = 6 years,
range = 0.5 – 38 years; lifetime use, Mdn = 15690 cones, range = 600 – 864000
cones). Meanwhile, CON used less than 50 times in their lifetime and did not use
in the past month. All subjects had no history of chronic medical illness or
neurological conditions, or any lifetime Axis I psychiatric disorder apart from
nicotine use disorder or cannabis use disorder, and had minimal illicit substance
use other than cannabis (<50 times in the past 10 years).
Measures
Participants’ demographic and substance use characteristics were assessed
separately at each individual research site. Select information (i.e. age, gender,
IQ, monthly tobacco (cigarettes) use, monthly standard alcoholic drinks, and
cannabis use measures) was subsequently standardised across sites (see
measures in Supplementary Table S1). Cannabis use measures included monthly
and

lifetime

cannabis

consumption

(measured

in

cones,

https://cannabissupport.com.au/media/1593/timeline‐followback.pdf), age of
initiation of regular cannabis use, and cannabis dependence.
Cannabis dependence information was only available from three of the four sites,
and was used to separate the aggregated three‐site sample into 70 CB‐dep, 50
CB‐nondep, and 106 CON based on recommended norms, and after excluding
subjects with missing dependence information. Specifically, in Amsterdam the
Mini

International

Neuropsychiatric

Interview’s

(MINI)

‘non‐alcohol

psychoactive substance use disorders’ module was used, with a cut‐off of 3 and
above as CB‐dep (Lecrubier, Sheehan, Weiller, Amorim, Bonora, Sheehan, Janavs
& Dunbar 1997), while Barcelona and Melbourne

used the Severity of

Dependence Scale (SDS), with a cut‐off of 4 and above as CB‐dep (Gossop, Darke,
Griffiths, Hando, Powis, Hall & Strang 1995).
Structural Image Processing
T1‐weighted structural MR images were acquired separately from each research
site. Scanner details have been documented previously (Batalla et al. 2013;
Solowij et al. 2013; Cousijn et al. 2014; Yücel et al. 2016; Chye et al. 2017a), as
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well as in the Supplementary Table S1. Two sites used a Phillips Intera 3T
scanner with an 8‐channel head coil (Amsterdam and Wollongong), one site used
a GE Signa Excite 1.5T scanner with an 8‐channel head coil (Barcelona), and one
site used a Siemens‐Trio 3T scanner with a 32‐channel head coil (Melbourne).
MR images were corrected for intensity inhomogeneity – nonparametric
nonuniform intensity normalisation (N3; Sled, Zijdenbos & Evans 1998) using
FreeSurfer image analysis (http://surfer.nmr.mgh.harvard.edu/) version 5.3.0.
An estimate of the intracranial volume (ICV) was also obtained from FreeSurfer’s
automated parcellation procedure. Subsequently, the images’ intensity was
standardised across sites, based on the average grey matter, white matter, and
cerebrospinal fluid intensity from each site, using the FMRIB Software Library
(FSL; http://www.fmrib.ox.ac.uk/fsl/). Finally, the images were visually
inspected to ensure consistent orientation along the anterior commissure‐
posterior commissure (AC‐PC) plane.
Volumetric Analysis
The hippocampus was manually traced by a trained tracer (Y.C.) blinded to
group and site membership, using the Analyze 12.0 software (AnalyzeDirect,
Overland Park, KS), according to a validated protocol (Velakoulis, Pantelis,
McGorry, Dudgeon, Brewer, Cook, Desmond, Bridle, Tierney, Murrie, Singh &
Copolov 1999). Hippocampal boundaries were defined posteriorly as the slice
with the greatest length of continuous fornix; medially as the open end of the
hippocampal fissure (posterior) and the uncal fissure (anterior); laterally as the
temporal horn of the lateral ventricle; inferiorly as the parahippocampal white
matter; and superiorly as the fimbria and alveus (posterior) as well as the
amygdala (anterior).
Intra‐ and inter‐rater reliabilities (i.e. Intraclass Correlation Coefficient (ICC),
absolute agreement, single measures) for the hippocampal tracing were assessed
on 28 randomly selected images. Intra‐rater reliabilities for the right and left
hippocampus were .97 and .88 respectively, while inter‐rater reliabilities against
an expert tracer (V.L.) were .90 and .93 respectively. Intra‐rater reliability was
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also consistent across scanner field strength, at an ICC of .95 (collapsed across
both hemispheres) for both 1.5T and 3T scanners. As tracing of all 261 images
proceeded over a four‐month period (from April 2016 to August 2016),
longitudinal intra‐rater reliability was performed on 15 images (i.e. 5 images
repeated 3 times, evenly distributed across the blinded sample). Values were .93
and .83 for the right and left hippocampus respectively, indicating good
consistency over time.
A series of univariate analysis of covariance (ANCOVA) models were run to
examine the association between cannabis use and dependence, and left and
right hippocampus volume. This included (i) comparison between CON and CB,
controlling for imaging site as random factor, gender as fixed factor, ICV, age, IQ,
monthly alcohol and tobacco use as covariates; (iia) comparison between CON,
CB‐nondep, and CB‐dep (only from the three sites that obtained dependence
measures – Amsterdam, Barcelona, Melbourne), controlling for all previously
mentioned variables; (iib) comparison between CB‐nondep and CB‐dep users
only, with additional inclusion of all cannabis use measures (current monthly
cones, lifetime cones and age of regular use) as covariates; and (iii) comparison
between CON, CB‐nondep, and CB‐dep, in a subset of subjects matched on
gender, age, IQ, and alcohol use across all groups, and matched on tobacco and
cannabis use (current monthly cones, lifetime cones and age of regular use)
across CB‐nondep and CB‐dep.
Shape Analysis
The manually‐traced hippocampal boundaries (i.e., object maps) were used to
run shape analysis within FSL. First, the object maps were registered to MNI
space, with reference from their respective T1‐weighted images. Next, average
boundary images for the hippocampal object maps (separately for the right and
left hippocampus) were obtained. To do this, we first averaged the object maps
together and binarised them at the 60% threshold. From this, we formed a one‐
voxel thick average boundary shape by subtracting away an eroded version of
the threshold‐shape. The signed distance of each individual hippocampal object
to every point on the average boundary shape could then be calculated. A flow
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chart of the shape analysis processing steps is presented in Supplementary Fig.
S1.
The signed distances for each hippocampal label were used for further statistical
analysis.

A

permutation‐based

approach

with

threshold‐free

cluster

enhancement (TFCE) was adopted using FSL’s Randomise tool (Smith & Nichols
2009; Winkler, Ridgway, Webster, Smith & Nichols 2014). A total of 100,000
permutations were used for the analysis, examining shape differences between
(i) CON versus CB, and (ii) CON versus CB‐nondep versus CB‐dep, and (iii) the
matched subset of CON versus CB‐nondep versus CB‐dep, all controlling for
imaging site, gender, age, IQ, alcohol use, and tobacco use.
Automated Segmentation vs. Manual Tracing
Given that it is often unfeasible for all studies, particularly studies with large
databases, to quantify brain structures via manual tracing, we further compared
the performance of the automated tool – FreeSurfer in hippocampal
segmentation, by replicating all volume and shape analysis. Hippocampal
segmentation was performed by FreeSurfer version 5.3, as described by Fischl,
Salat, Busa, Albert, Dieterich, Haselgrove, van der Kouwe, Killiany, Kennedy,
Klaveness, Montillo, Makris, Rosen & Dale (2002). Shape analysis was also
performed with a similar processing step as presented in Supplementary Fig. S1.
The automated segmentation procedure was also validated against our manual
tracing, which is considered the gold standard for evaluating hippocampal
volume (Velakoulis et al. 1999), by examining the (i) correlation between both
methods, and the (ii) percent volume overlap (i.e. Dice coefficient, DICE) as
defined by the equation
∩
⁄2

100

RESULTS
Sample Characteristics
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Participant characteristics and hippocampal volume measures (i) by cannabis
use (i.e. CON vs. CB) and (ii) by cannabis dependence (i.e. CON vs. CB‐nondep vs.
CB‐dep), are presented in Tables 1 and 2 respectively. The separate data from
each imaging site are presented in Supplementary Tables S2 and S3.
A subset of matched CON, CB‐nondep, and CB‐dep were selected, to verify
volumetric findings. CB‐nondep and CB‐dep were matched on age, gender, IQ
alcohol, tobacco, and cannabis use pattern within each site. This was done by
first obtaining the mean and standard deviation of each continuous variable of
the smallest/reference group (i.e. x̅ ref and σ ref respectively) by site. Subsequently,
each subject’s distance score (D) from the reference group, on all variables, was
calculated using the equation

̅

.

⁄

.

where v = the variables: age, IQ, alcohol, tobacco, cannabis onset, cannabis
monthly use, and cannabis lifetime use. Cannabis‐using subjects were ranked
and selected by their distance from the reference group. Meanwhile, control
subjects were first selected for smoking status, due to the relatively low number
of tobacco users in CON relative to CB. Subsequently, the previous equation was
applied to select for CON with the lowest distance from the reference group, with
regards to age, IQ, alcohol, and tobacco use. Nevertheless, we were unable to
match CON to CB‐nondep and CB‐dep on tobacco use, from the Melbourne site.
Characteristics and hippocampal volume measures of their matched subset is
presented in Table 3, and by imaging site in Supplementary Table S4.
Hippocampal volume comparisons by cannabis use – manual tracing
CON and CB did not differ significantly in right or left hippocampal volume
(Table 1)†. Females had smaller hippocampi compared to males (F1,250 = 12.02
and 20.00 for the right and left hippocampus respectively, p ≤ .001, ηp2 ≥ .046). A
Four CON from the Amsterdam site used between 15 to 50 cannabis joints in their lifetime.
When analysis was re‐run excluding these subjects, the insignificant group effect remained (F1,246
= 2.32 and 1.58, p = .13 and .21) for the right and left hippocampus respectively.
†
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site effect was also found (F3,250 = 12.34 and 10.65 for the right and left
hippocampus respectively, p < .001, ηp2 ≥ .129), with participants from Barcelona
demonstrating smaller hippocampi than participants from every other site (p ≤
.006) while participants from Amsterdam had larger hippocampi than
participants from Melbourne (p ≤ .018). IQ significantly affected left
hippocampus volume (F1,250 = 4.33, p = .039, ηp2 = .017). None of the other
covariates (i.e. age, IQ, alcohol use and tobacco use) were statistically significant
in the model (p ≥ .054, ηp2 ≤ .015).
Hippocampal volume comparisons by cannabis dependence – manual tracing
Analyses comparing CON, CB‐nondep, and CB‐dep (from three sites) revealed a
significant effect of dependence group in the right (F2,215 = 5.91, p = .003, ηp2 =
.052, medium effect size) and left (F2,215 = 4.49, p = .012, ηp2 = .040, medium effect
size) hemisphere (Table 2)‡. CB‐dep had significantly smaller right and left
hippocampi compared to both CON (p = .003 and .008) and CB‐nondep (p = .006
and .016) (Fig. 1). As in the four‐site analysis, gender (F1,215 = 16.39 and 27.57 for
right and left hippocampus respectively, p < .001) and site effects (F2,215 = 19.18
and 15.89 for right and left hippocampus respectively, p < .001) were significant.
Females had smaller hippocampi than males, and again participants from the
Barcelona site had smaller hippocampi than those from the other two sites (p ≤
.001), while participants from the Amsterdam site had larger hippocampi than
those from Melbourne (p ≤ .026). None of the covariates were statistically
significant in the model (p ≥ .087, ηp2 ≤ .014).
To establish the specificity of volumetric differences to cannabis dependence
rather than cannabis use or exposure (and particularly since CB‐dep had
significantly greater monthly use than CB‐nondep), CB‐dep and CB‐nondep were
further compared, additionally controlling for cannabis use measures (current
monthly cones, lifetime cones and age of regular use). The significant group
difference persisted, with CB‐dep showing smaller right (F1,104 = 6.02, p = .016,

‡

Four CON from the Amsterdam site used between 15 to 50 cannabis joints in their lifetime.
When analysis was re‐run excluding these subjects, the significant dependence effect remained
(F2,211 = 5.72 and 4.41, p = .004 and .013) for the right and left hippocampus respectively.
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ηp2 = .055, medium effect size) and left hippocampi (F1,104 = 6.19, p = .014, ηp2 =
.056, medium effect size) than CB‐nondep after controlling for these cannabis
use measures.
Hippocampal volume comparisons by cannabis dependence in matched
subset – manual tracing
Finally, the subset of matched CON, CB‐nondep, and CB‐dep were compared on
hippocampal volume. Gender distribution, age, IQ, alcohol use, and tobacco use
were matched across groups within each site, apart from Melbourne, for which
we were unable to match tobacco use. Furthermore, CB‐nondep and CB‐dep
were matched on all previously mentioned variables (i.e. gender, age, IQ, alcohol,
and tobacco use), and cannabis use pattern. The effect of cannabis dependence
persisted for the right (F1,112 = 3.97, p = .022, ηp2 = .066) and left hippocampi
(F1,112 = 3.15, p = .047, ηp2 = .053). CB‐dep users demonstrated significantly
smaller hippocampi than CB‐nondep users in both hemispheres (p = .016 and p =
.022 respectively), and a smaller right hippocampus than CON (p = .020).
Hippocampal shape comparisons by cannabis use and dependence – manual
tracing
Cluster‐based shape analysis was performed controlling for ICV, imaging site,
gender, IQ, age, alcohol use and tobacco use. Comparison between (i) CON and
CB revealed no significant shape difference between groups. However,
comparison between (ii) CON, CB‐nondep, and CB‐dep demonstrated a
significant shape difference between CB‐nondep and CB‐dep in the right and left
hippocampus (Fig. 2A‐D), but not between CON and CB‐nondep, or CON and CB‐
dep§. Specifically, deflation occurred along the superior‐medial body of the
hippocampi of CB‐dep relative to CB‐nondep. Nevertheless, when comparison
was performed between the subset of (iii) matched CON, CB‐nondep, and CB‐
dep, deflation in CB‐dep relative to CB‐nondep did not survive FWE‐correction
across the image space.

§ Four CON from the Amsterdam site used between 15 to 50 cannabis joints in their lifetime.
When analysis was re‐run excluding these subjects, results remained similar.
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Hippocampal volume and shape ‐ FreeSurfer vs. manual tracing
All hippocampal volume and shape analyses were replicated using the
automated segmentation software FreeSurfer. FreeSurfer performance was also
validated, relative to manual tracing, by examining the correlation between both
methods, and the percent volume overlap. Results for FreeSurfer‐segmented
hippocampal comparison between (i) CON and CB, (iia) CON, CB‐nondep and CB‐
dep, (iib) CB‐nondep and CB‐dep only, and (iii) matched subset of CON, CB‐
nondep, and CB‐dep are presented in Supplementary Table 5. Briefly, there was
no significant hippocampal volume difference between CON and CB, but CB‐dep
users similarly showed a larger left hippocampus than CB‐nondep users (p =
.013). When only CB‐nondep and CB‐dep users were compared, additionally
controlling for cannabis use pattern, CB‐dep users again demonstrated
significantly larger right and left hippocampi relative to CB‐nondep users (p =
.027 and p = .005 respectively). When the matched subset of CON, CB‐nondep,
and CB‐dep were compared however, no significant dependence effect was
found. Cluster‐based shape analysis of FreeSurfer‐segmented hippocampi
meanwhile only demonstrated a shape difference between CB‐dep and CB‐
nondep users that did not survive FWE‐correction. While the FreeSurfer
segmented hippocampi were strongly correlated with the manual tracing
(R=0.72 and 0.66 for the right and left hippocampus respectively, p < .001), the
FreeSurfer hippocampi are systematically larger than the manual output, as
illustrated in the Bland‐Altman plot (Supplementary Fig. S3). Estimation of
volume overlap between both methods suggests an average volume overlap of
71.2% (SD = 4.39%) and 70.10% (SD = 4.75%) for the right and left
hippocampus respectively. The larger hippocampal volume produced by
FreeSurfer may be due to its greater tendency to include surrounding structures
and cerebrospinal fluid (CSF), as illustrated in example slices in Supplementary
Fig. S3.
DISCUSSION
In this large‐scale multi‐site study, we demonstrated significant hippocampal
volume reduction only in cannabis dependent users relative to both non‐user
controls and non‐dependent users, irrespective of extent of cannabis use. Shape
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difference was also observed in the right and left hippocampus, only in
dependent users (deflation of the superior‐medial body) relative to non‐
dependent users. These results suggest that hippocampal volume and shape
alterations may be specific to cannabis dependence rather than non‐dependent
regular cannabis use. Our findings are consistent with previous work reflecting
dependence‐specific effects, for example in neuroanatomical and functional
alteration across the cortical and limbic regions (Filbey & Dunlop 2014; Chye et
al. 2017b a). Future investigative efforts should thus be mindful in assessing and
discriminating between cannabis use and dependence when evaluating the
harms and vulnerabilities associated with chronic cannabis use.
Hippocampal volumetric reduction is the most consistently reported
neuroanatomical finding in regular cannabis users relative to non‐users
(Rocchetti et al. 2013; Koenders et al. 2016; Yücel et al. 2016; Lorenzetti et al.
2016c; Chye et al. 2017b), but was not observed in all studies (e.g., Gilman et al.,
2014; Mashhoon et al., 2015; Medina et al., 2007; Tzilos et al., 2005; Weiland et
al., 2015). We were well‐powered to detect group differences in a large sample
(aggregated across well‐controlled studies from four international research
sites), and found no volume reduction in cannabis use per se, but specifically in
dependent users. Notably, these findings were not driven by cannabis use level
(i.e, monthly or lifetime use), suggesting cannabis dependence‐specific effects on
hippocampal morphology to be dissociated from those due to level of cannabis
use. This contrasts previous reports of a dose‐dependent association between
hippocampal volume and cannabis dosage (Yücel et al. 2008; Ashtari et al. 2011;
Cousijn, Wiers, Ridderinkhof, Brink, Veltman & Goudriaan 2012). However, none
of the aforementioned studies discriminated between dependent and non‐
dependent users in their samples, and might not have been able to dissociate
hippocampal differences linked to dosage versus dependence. Indeed, less than
40% of frequent cannabis users (i.e. using ≥3 days per week for ≥1 year) will
develop a dependence syndrome, irrespective of level of use (van der Pol,
Liebregts, de Graaf, Korf, Van den Brink & Van Laar 2013c). This distinction in
the cannabis user population (i.e. dependence vs. non‐dependence) may explain
why a number of studies have failed to detect hippocampal volume differences in
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cannabis users compared to controls, as these studies may have included varying
proportions of dependent and non‐dependent users (Tzilos et al. 2005; Medina
et al. 2007; Gilman et al. 2014; Weiland et al. 2015; Mashhoon et al. 2015).
We also found a localised shape difference between dependent and non‐
dependent users along the superior‐medial body of the hippocampus, roughly
coinciding with the cornu ammonis and dentate gyrus (CA3 and CA4/DG)
regions (Finegersh, Avedissian, Shamim, Dustin, Thompson & Theodore 2011).
While this result did not survive FWE correction in the subset of users matched
on age, IQ, and substance use, it is possible that the smaller sample (i.e., from 226
in the original analysis, to 123 in this analysis) resulted in reduced power to
detect subtle shape effects. Hippocampal shape alterations in cannabis users
have only been examined in four prior studies, demonstrating regional shape
differences in current users, recreational users (Mdn = 6‐10 lifetime use), and
users with a past cannabis use disorder (Solowij et al. 2013; Smith, Cobia, Reilly,
Gilman, Roberts, Alpert, Wang, Breiter & Csernansky 2015; Orr, Paschall &
Banich 2016; Koenders, Lorenzetti, Haan, Suo, Vingerhoets, Van den Brink,
Wiers, Meijer, Machielsen, Goudriaan, Veltman, Yücel & Cousijn 2017). Our
finding is consistent with previous reported alterations in regular cannabis users
(i.e. shape deflation along the hippocampal head and body (Solowij et al. 2013;
Koenders et al. 2017)) and in dependent users (i.e., reduced CA3 and CA4/DG
volume (Chye et al. 2017b)). Deflation confined to the CA3 and CA4/DG
hippocampal subregions is noteworthy as these are the major sites for adult
neurogenesis and subsequent innervation of new neurons, a process crucial for
learning and memory, as well as affective and stress regulation (Canales 2007;
Chambers 2013). Indeed, poorer cognitive and emotive functioning are
documented in dependent cannabis users (Solowij & Battisti 2008; van der Pol et
al. 2013a; Broyd et al. 2016). We were unfortunately unable to explore whether
cannabis dependence‐related hippocampal morphology mediates differences in
cognitive and emotive functioning (e.g., depressive or anxiety symptoms) in the
current study. Such knowledge may be useful for understanding the interaction
between cannabis dependence and functioning in relation to brain structure, and
presents a potential avenue for future work.
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Prominent theories of addiction propose that vulnerabilities in the decision‐
making process coupled with distress associated with negative mood states are
the key drivers in persistent substance taking observed in substance dependence
(Koob 2008; Koob & Le Moal 2008; Redish, Jensen & Johnson 2008; Volkow &
Morales 2015). Our finding of hippocampal alteration specific to cannabis
dependence supports theories suggesting dependence‐specific neuroalterations.
The amygdala‐hippocampal system is involved in affective processing (Ekhtiari,
Victor & Paulus 2017), with impaired hippocampal functioning (e.g. low
hippocampal neurogenesis) further linked to poor stress regulation (Hyman &
Sinha 2009; Schloesser, Manji & Martinowich 2009). Increased stress reactivity
and negative mood state pose a vulnerability factor which is strongly associated
with dependence in cannabis users, beyond and distinct from extent of cannabis
use (Stewart 2003; Koob 2009; van der Pol et al. 2013c). Additionally,
hippocampal function is also necessary to guide learning and adaptive behavior,
with impaired function suggested to restrict the complexity and flexibility of
motivational learning that subserves the extinction of substance use behavior,
thus contributing to the maintenance of dependence (Canales 2007; Chambers,
Bickel & Potenza 2007; Redish et al. 2008; Chambers 2013). While future efforts
are necessary to expand on the link between hippocampal neuroanatomy and
the cognitive, stress, and affective regulation process guiding cannabis
dependence, it nonetheless appears that dependent cannabis users may be
distinctly impacted in neuroanatomy (Filbey & Yezhuvath 2013; Chye et al.
2017b a).
Finally, we compared the consistency between two separate methods of
measuring hippocampal volumes i.e. FreeSurfer and manual segmentation (see
Supplementary Material 2), and showed that these were highly correlated (about
70% volume overlap). FreeSurfer produced systematically larger hippocampi
than did manual segmentation, which may be due to its greater tendency to
include surrounding structures and cerebrospinal fluid (see example slices in
Supplementary Fig. S3). However, we still found a significant effect of cannabis
dependence in FreeSurfer‐segmented hippocampi (i.e. in analyses controlling for
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cannabis use pattern, but not in the matched subset analyses, Supplementary
Table S5), suggesting mostly consistent results from both methods. The manual
segmentation method is considered the gold standard for evaluating
hippocampal volume (Velakoulis et al. 1999), and assumed to be superior to
automated methods (i.e. SPM, FSL, FreeSurfer), as it allows for a more fine‐
grained inspection of hippocampal volume and shape. Meanwhile FreeSurfer’s
estimations of hippocampal volume tend to show a larger variance, in addition to
a tendency to underestimate grey matter volume with increasing scanner noise,
causing it’s output to be more subject to hardware‐related differences (Butts
2013; Wenger, Mårtensson, Noack, Bodammer, Kühn, Schaefer, Heinze, Düzel,
Bäckman, Lindenberger & Lövdén 2014; Fellhauer, Zöllner, Schröder, Degen,
Kong, Essig, Thomann & Schad 2015). As such, when assessing impacts on the
morphology of the hippocampus, it may be preferable for studies to adopt
manual tracing methods wherever feasible.
Some limitations of this study must be addressed. Collating a mega‐analysis from
multiple imaging sites meant that site‐related factors such as scanner differences
and geographical differences could have confounded the results. To address this,
we controlled for imaging site in all our group analyses. Furthermore, the
hippocampal volume of cannabis dependent users was clearly reduced relative
to non‐dependent users and controls at every site, suggesting that no single site
was driving the observed results (Supplementary Figure S2). Secondly, the cross‐
sectional nature of our analysis precludes interpretation on the causality of the
effects, i.e. whether altered hippocampal morphology pre‐exists or is consequent
to cannabis use and dependence. Finally, as different imaging sites have adopted
different instruments in measuring cannabis dependence, we could not directly
compare levels of dependence severity with hippocampal morphology across
sites or examine severity in regression models. Instead, we adopted validated
cut‐offs (Lecrubier et al. 1997; Swift, Copeland & Hall 1998; van der Pol,
Liebregts, de Graaf, Korf, van den Brink & van Laar 2013b) to consistently
investigate hippocampal morphology between dependent and non‐dependent
users. Studies using consistent diagnostic instruments of substance use
disorders (e.g. DSM‐5; American Psychiatric Association 2013) are needed to
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verify the association between hippocampal morphology and dependence
severity, particularly in

further

delineating the relationship between

dependence, cognitive and affective regulation, and the neuroanatomy of
substance users (Lorenzetti, Cousijn, Solowij, Garavan, Suo & Verdejo‐García
2016a; Lorenzetti, Solowij, Suo, Walterfang, Lubman, Verdejo‐García, Cousijn,
Pantelis, Fornito & Yucel 2016b; Lorenzetti et al. 2016c; Solowij, Lorenzetti &
Yücel 2016).
Conclusion
We extend on previous studies of hippocampal morphological alteration (i.e.
shape and volume) in non‐dependent and dependent cannabis users in a large
multisite‐imaging cohort, using both manual tracing and automated methods.
Hippocampal volume reduction was specific to dependent users, even after
controlling for cannabis dosage and sample characteristic (i.e. age, IQ, alcohol
and tobacco use). There was also an emerging shape difference along the
superior‐medial boundary of the hippocampus, between dependent and non‐
dependent users. Our findings suggest that not all cannabis users are alike, with
a sub‐group of vulnerable users – dependent users – showing hippocampal
morphological alterations compared to non‐dependent users and controls.
Further steps should be made to characterise and verify the neural and
behavioral differences that separate non‐dependent and dependent cannabis
users in large normative samples and treatment seeking populations, whether as
vulnerability factors or consequent of use, to better identify and pre‐empt the
transition of cannabis users to dependence.
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Table 1 Sample characteristics and MR volumetric measures of controls (CON)
and cannabis users (CB) averaged across 4 sites (mean (SD)).
CON

CB

t259/X2

N = 121

N = 140

Age (years)

26.12 (9.03)

28.03 (10.25)

1.58

Gender (% M / F)

70.25 / 29.75

67.14 / 32.86

0.29

IQ a

109.31 (10.54)

103.45 (10.74)

4.44***

Alcohol (StDr/mth) b

19.87 (23.77)

24.43 (25.18)

1.50

Tobacco (Cig/mth) b

30.88 (97.92)

254.96 (233.77)

9.82***

Age of Regular Use

‐

17.84 (3.38)

‐

Current Use

‐

334.08 (322.32)

‐

‐

57,107 (99,987)

‐

1.55 (0.20)

1.52 (0.17)

1.31

Manual

2,584.45 (362.77)

2,411.68 (316.24)

2.50d

FreeSurfer c

4,509.66 (469.21)

4,381.56 (414.04)

0.00d

Manual

2,455.05 (342.42)

2,314.68 (307.18)

1.56d

FreeSurfer c

4,467.87 (434.48)

4,334.63 (434.42)

0.04d

Cannabis Use

(cones/month)
Lifetime Use (cones)
Volumetric measures (mm3)
Intracranial Volume (106)
Right hippocampus

Left hippocampus

a Estimated

IQ measured with the Dutch version of the National Adult Reading Test (DART;

Schmand, Bakker, Saan & Louman 1991) (Amsterdam), the vocabulary subscale of the Wechsler
Adult Intelligence Scale – Third Edition (WAIS‐III; Wechsler 1997) (Barcelona); the National
Adult Reading Test (NART; Nelson 1982) (Wollongong); and the Wechsler Abbreviated Scale of
Intelligence (WASI; Wechsler 1999) (Melbourne).
b

StDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month

c Two CON subjects were excluded due to poor FreeSurfer hippocampal segmentation (i.e. outlier

with hippocampal volume of 2204.48 and 2037.21 respectively), resulting in n of CON = 119.
d

F statistic for group comparison of hippocampal volume, controlling for imaging site as random

factor, gender as fixed factor, ICV, age, IQ, monthly alcohol and tobacco use as covariates. See
Supplementary Table S5 for full results.
*p < .05, **p < .01, ***p < .001
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Table 2 Sample characteristics and MR volumetric measures of controls (CON),
non‐dependent (CB‐nondep) and dependent (CB‐dep) cannabis users averaged
across 3 sites (mean (SD))
T223/X2

CON

CB‐nondep

CB‐dep

N = 106

N = 50

N = 70

Age (years)

24.77 (7.91)

27.07 (10.33)

26.74 (9.18)

1.61

Gender (% M / F)

66.98 / 33.02

60.00 / 40.00

64.29 / 35.71

0.73

IQ a

108.65 (10.71)

103.03 (11.13)

102.13 (10.86)

9.15***d

Alcohol (StDr/mth) b

18.70 (23.90)

21.54 (25.03)

21.88 (22.78)

0.46

Tobacco (Cig/mth) b

30.94 (96.72)

236.90

219.72

35.89***e

(249.97)

(197.66)

Cannabis Use
Age of Regular Use

‐

17.79 (2.66)

17.44 (3.23)

0.61

Current Use

‐

229.81

351.64

‐2.54*

(202.25)

(290.95)

32,375

50,431

(47,641)

(72,812)

1.53 (0.19)

1.46 (0.19)

1.53 (0.15)

2.72

2,542.21

2,474.32

2,340.50

5.91**f

(323.36)

(326.97)

(287.51)

4476.59

4425.79

4374.22

(449.19)

(379.48)

(422.98)

2,420.41

2,368.56

2,250.19

(312.78)

(329.54)

(278.38)

4453.60

4386.12

4299.16

(418.80)

(446.93)

(422.87)

(cones/month)
Lifetime Use (cones)

‐

‐1.54

Volumetric measures (mm3)
Intracranial Volume (106)
Right hippocampus
Manual
FreeSurfer c

2.04f

Left hippocampus
Manual
FreeSurfer c
a Estimated

4.49*f
3.22**f

IQ measured with the Dutch version of the National Adult Reading Test (DART;

Schmand, Bakker, Saan & Louman 1991) (Amsterdam), the vocabulary subscale of the Wechsler
Adult Intelligence Scale – Third Edition (WAIS‐III; Wechsler 1997) (Barcelona); and the Wechsler
Abbreviated Scale of Intelligence (WASI; Wechsler 1999) (Melbourne).
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b

StDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month

c Two CON subjects were excluded due to poor FreeSurfer hippocampal segmentation (i.e. outlier

with hippocampal volume of 2204.48 and 2037.21 respectively), resulting in n of CON = 104.
d

CON > CB‐nondep, p = .003; CON > CB‐dep, p <.001

e CON
f

< CB‐nondep, p < .001; CON < CB‐dep, p <.001

F statistic for group comparison of hippocampal volume, controlling for imaging site as random

factor, gender as fixed factor, ICV, age, IQ, monthly alcohol and tobacco use as covariates. See
Supplementary Table S5 for full results.
*p < .05, **p < .01, ***p < .001
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Table 3 Sample characteristics and MR volumetric measures of controls (CON),
non‐dependent (CB‐nondep) and dependent (CB‐dep) cannabis users in matched
subset, averaged across 3 sites (mean (SD))
CON

CB‐nondep

CB‐dep

F2,120/X2

N = 41

N = 41

N = 41

Age (years)

26.09 (8.68)

28.58 (10.81)

26.71 (8.54)

0.79

Gender (% M / F)

63.4 / 36.6

63.4 / 36.6

63.4 / 36.6

0.00

IQ a

107.35 (8.87)

103.33 (12.11)

103.92 (8.78)

1.92

Alcohol (StDr/mth) b

24.39 (27.15)

20.65 (22.84)

20.52 (17.22)

0.38

Tobacco (Cig/mth) b

76.28 (143.36)

238.83 (253.82) 213.64 (187.22) 7.84** c

Age of Regular Use

‐

17.82 (2.81)

Current Use

‐

235.40 (209.86) 278.94 (172.76) 1.03

‐

38,340 (50,702) 37,288 (45,640) 0.10

1.54 (0.17)

1.49 (0.18)

1.50 (0.17)

0.40

2,525.00

2,466.44

2,355.56

3.97*d

(311.25)

(290.37)

(310.13)

4,487.90

4,454.43

4,366.09

(451.50)

(341.31)

(436.79)

2,373.05

2,366.93

2,246.15

(316.76)

(313.91)

(287.54)

4,500.68

4,413.65

4,309.69

(458.74)

(421.80)

(462.13)

Cannabis Use
17.48 (2.58)

0.57

(cones/month)
Lifetime Use (cones)
Volumetric measures (mm3)
Intracranial Volume (106)
Right hippocampus
Manual
FreeSurfer

1.22d

Left hippocampus
Manual
FreeSurfer
a Estimated

3.15*d
1.82d

IQ measured with the Dutch version of the National Adult Reading Test (DART;

Schmand, Bakker, Saan & Louman 1991) (Amsterdam), the vocabulary subscale of the Wechsler
Adult Intelligence Scale – Third Edition (WAIS‐III; Wechsler 1997) (Barcelona); and the Wechsler
Abbreviated Scale of Intelligence (WASI; Wechsler 1999) (Melbourne).
b

StDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month

c

CON < CB‐nondep, p < .001; CON < CB‐dep, p = .002
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d

F statistic for group comparison of hippocampal volume, controlling for imaging site as random

factor, gender as fixed factor, ICV, age, IQ, monthly alcohol and tobacco use as covariates. See
Supplementary Table S5 for full results.
*p < .05, **p < .01, ***p < .001

Figure Legend

Fig. 1 Right and left hippocampal volume in controls (CON), non‐dependent (CB‐
nondep) and dependent (CB‐dep) cannabis users, corrected for intracranial
volume (ICV) and gender; bars represent 95% confidence interval; *p < .05 **p <
.01.
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Fig.. 2 (A,B) Cross‐secti
C
onal coron
nal, axial and sagittall slices of MR scans and
(C,D
D) 3D ren
ndering of the rightt and left hippocam
mpus, depiccting areas of
defllation in hippocampall shape in C
CB‐dep com
mpared to CB‐nondep
C
users.
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